Message from the ISV President
I am delighted to serve as your 2026 and 2027 President of the International Society for Vaccines (ISV). Our Society brings together colleagues from all over the world and aims to encourage, establish, and promote the development and use of vaccines and immuno-therapeutics to prevent and control infectious and non-infectious diseases in animals and humans.
Visit our socials:
Manon MJ Cox, PhD, MBA
ISV News & Insights
President’s
End-of-Term Report
(Jan. 2024 – Dec. 2025)
Linda S. Klavinskis, PhD
(ISV President 2024-2025)
Professor of Viral Immunology,
Department of Infectious Diseases,
King’s College London
As the 2024–2025 presidential term comes to a close, I am delighted to celebrate a period of remarkable growth, achievement, and global impact for the International Society for Vaccines (ISV), and thank all who were involved in contributing to these successes and to our members who actively engaged in ISVs activities to advance vaccine science worldwide.
It has been a great honour to serve as the President and to work alongside such an inspiring, dedicated, and passionate global community.
My term has been defined by new initiatives, global collaboration, and a shared commitment to excellence, guided by the missions I set out in January 2024 to advance our society and strengthen its global impact. Here’s a snapshot of what we have achieved together:
ISV December Webinar
Recording Now Available!
Vaccines in the Era of Artificial Intelligence.
Rino Rappuoli, Biotecnopolo di Siena Foundation, Italy
ISV Annual Supporters
Partners
Gold
Silver
Other
2025 ISV Annual Congress Exhibitors
